Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
Prostate cancer is the most common nonskin malignancy among men in the United States. Since the introduction of screening with prostate-specific antigen (PSA), most patients are being diagnosed at an early stage with low-risk disease. For men with low-risk prostate cancer, there exists an array of r...
Saved in:
Main Authors: | Kevin S. Choe, Stanley L. Liauw |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2010.179 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
by: Siebren Dijkstra, et al.
Published: (2012-01-01) -
Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma
by: Zi-Qi Pan, et al.
Published: (2020-01-01) -
The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
by: Daniel W. Smith, et al.
Published: (2012-01-01) -
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
by: Pim J. van Leeuwen, et al.
Published: (2016-01-01) -
HDR Brachytherapy in the Management of High-Risk Prostate Cancer
by: Susan Masson, et al.
Published: (2012-01-01)